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Abstract: Leptospirosis is the most neglected widespread zoonosis worldwide. In Spain, leptospirosis
reports in people and animals have increased lately. Cats can become infected with Leptospira, as well
as be chronic carriers. The aim of this study was to determine serological antibody prevalence against
Leptospira sp., blood DNA, and shedding of DNA from pathogenic Leptospira species in the urine of
cats in Spain. Microagglutination tests (MAT) and blood and urine TaqMan real-time polymerase
chain reaction (PCR) were performed. Leptospira antibodies were detected in 10/244 cats; with 4.1%
positive results (95% confidence interval (CI): 2.1–7.18%). Titers ranged from 1:20 to 1:320 (serovars
Ballum; Bataviae; Bratislava; Cynopteri; Grippotyphosa Mandemakers; Grippotyphosa Moskva;
Pomona; and Proechimys). The most common serovar was Cynopteri. Blood samples from 1/89 cats
amplified for Leptospira DNA (1.12%; 95% CI: 0.05–5.41%). Urine samples from 4/232 cats amplified
for Leptospira DNA (1.72%; 95% CI: 0.55–4.10%). In conclusion free-roaming cats in Spain can shed
pathogenic Leptospira DNA in their urine and may be a source of human infection. Serovars not
previously described in cats in Spain were detected; suggesting the presence of at least 4 different
species of pathogenic leptospires in the country (L. borgpetersenii; L. interrogans; L. kirschneri; and
L. noguchii).
Keywords: antibodies; free-roaming cat; leptospirosis; PCR; shedding; serovar; zoonoses
1. Introduction
Leptospirosis is a zoonosis present in every continent except Antarctica. The vast majority
of mammals have been shown to be hosts of Leptospira [1,2]. Worldwide, 1.03 million cases of
Leptospira infections in humans have been estimated per year, of which 58,900 correspond to deaths [3].
The incidence of human leptospirosis in Spain is 0.86 cases per million inhabitants. Catalonia and
Extremadura are two of the autonomous communities with the highest reported cases [4,5]. It has been
shown that some pathogenic species of leptospires like Leptospira borgpetersenii, Leptospira interrogans,
and Leptospira kirschneri can naturally infect cats [6–8]. Clinical presentation of the disease is rare and
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usually mild in cats [9–12]. Several studies in different geographical areas have demonstrated that cats
have contact with Leptospira since they develop specific antibodies ranging from 4% to 33.3%, with
no clear association to clinical disease [13–17]. Urinary shedding of Leptospira DNA has also been
documented in cats, with a prevalence ranging up to 67.8% depending on various factors including
the geographical area, the presence in the area of farm animals infected with leptospires, and prey
habits [7,14,15,18–21]. Furthermore, a recent study investigated the ability of cats to excrete viable
bacteria through urine (p. 227, [19]), suggesting the possibility that cats can spread the bacteria by
urine and infect humans. Sequences from bacterial DNA isolated in acute human cases of leptospirosis
and wild animals have shown similarities with those isolated from cats in Reunion Island (Leptospira
borgpetersenii); the authors of the work rejected, however, any major role of feral cats in the epidemiology
of leptospirosis in that geographical region due to urinary Leptospira shedding cats extremely low
prevalence (0.6%) [8]. Conversely, other researchers argue that the role of cats in the maintenance of
the pathogen has so far been underestimated [6,15,19]. It is possible that cats have an important role as
leptospires carriers, contributing to their maintenance in the environment and favouring the zoonotic
risk. The aim of this study was to evaluate the presence of antibodies against pathogenic Leptospira
species and to determine the presence of Leptospira DNA in urine and blood by means of polymerase
chain reaction (PCR), in free-roaming cats from two different geographical areas in Spain.
2. Materials and Methods
Sample size was determined based on the formula (n = Z2 × P × (1−P) /d2 where n = required
sample size; Z = Z statistic for a level of confidence; P = expected prevalence or proportion based on
literature in proportion of one; and d = precision in proportion of one), proposed for prevalence studies.
Based on an assumed prevalence of antibodies against Leptospira species in cats of 17.9% and leptospiral
DNA shedding in urine of 3.3% [15], a sample size of 226 cats (95% CI; 5% precision) was required for
antibody prevalence and 194 cats (99.9% CI; 5% precision) for DNA urinary shedding study.
2.1. Animals in the Study
Animals from two different geographical regions of Spain (Barcelona, Catalonia, in the northeast
and Cáceres, Extremadura, in the southwest) were used in this prospective trial. Two hundred and
forty-four cats were recruited from October 2017 to September 2018. Cats from Barcelona (90/244)
were part of a neutering program and were housed in local animal shelters in Barcelona; cats from
Extremadura (154/244) were part of a free-roaming cat spay program in Cáceres. Owing to the feral
nature of most cats, prior history was not available. Data for gender, estimated age, and breed were
collected. Signed informed consent was obtained from all animal shelters. Sampling collection was
performed under the guidelines of the Ethical Committee Animal Care and Research, Autonomous
University of Barcelona, approval number CEEAH, code 2939.
2.2. Sample Collection
In all cases, samples were collected with the cat under general anaesthesia. Three ml of venous
jugular blood, collected from each animal, was divided and 1 ml was transferred to a K3-EDTA tube and
2 ml to a serum separator tube. K3-EDTA tubes were frozen at −20 ◦C until the DNA extraction. Serum
separator tubes were centrifuged at 1300 × g, 5 minutes, within 5 hours of collection and the serum was
stored at −20 ◦C until testing for leptospiral antibodies. Urine was collected by direct cystocentesis
in sterile syringes and centrifuged at 14,000× g, 15 minutes at room temperature. The supernatant
was discarded, and the pellet was re-suspended in a ratio of 1:1 with 0.5 ml Buffer phosphate-buffered
saline (PBS) (pH 7.6, 0.01 M, Canvax, Córdoba, Spain). The final pellet volume (1ml) was stored at
−20 ◦C until DNA extraction was performed. All cats were tested for feline leukaemia virus, FeLV and
feline immunodeficiency virus, FIV, using a commercial test (SNAP Combo FeLV/FIV test®, IDEXX,
Barcelona, Spain).
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2.3. Microscopic Agglutination Test (MAT)
Microscopic agglutination test (MAT) was performed at the OIE and National Collaborating Centre
for Reference and Research on Leptospirosis, Amsterdam, the Netherlands. MAT was performed by
direct reading following a technique described before [22]. When a reaction was observed, it was
re-checked by indirect reading. Two-fold serial dilutions of serum from 1:20 to 1:160 were tested; this is
including the antigen. In the case of animals with titers ≥1:160, the test was repeated, with a serial
dilution series from 1:20 to 1:10240. Any antibody titer ≥1:20 was considered as a positive value [23].
Serum was examined for antibodies against 8 species of Leptospira, belonging to 20 serogroups, 27
serovars, and 28 strains (Table 1). Saprophytic strains L. biflexa strain Patoc I, L. biflexa strain CH 11, and
L. meyeri strain Veldrat Semarang 173, were included in our panel diagnostic according to the World
Health Organization’s guidance [24].
Table 1. Species, serogroup, serovar, and strain from Leptospira tested among 244 cats from Spain.
SPECIES (8) SEROGROUP (20) SEROVAR (27) STRAIN (28)
L. biflexa * Andaman Andaman CH 11
L. interrogans Australis Australis Ballico
L. interrogans Australis Bratislava Jez Bratislava
L. interrogans Autumnalis Rachmati Rachmat
L. borgpetersenii Ballum Ballum Mus 127
L. interrogans Bataviae Bataviae Swart
L. interrogans Canicola Canicola Hond Utrecht IV
L. weilii Celledoni Celledoni Celledoni
L. kirschneri Cynopteri Cynopteri 3522 C
L. kirschneri Grippotyphosa Grippotyphosa Mandemakers
L. kirschneri Grippotyphosa Grippotyphosa type Moska Moskva V
L. interrogans Hebdomadis Hebdomadis Hebdomadis
L. interrogans Icterohaemorrhagiae Copenhageni Wijnberg
L. interrogans Icterohaemorrhagiae Icterohaemorrhagiae Kantorowic
L. borgpetersenii Javanica Poi Poi
L. borgpetersenii Mini Mini Sari
L. noguchii Panama Panama CZ 214
L. interrogans Pomona Pomona Pomona
L. noguchii Pomona Proechimys 1161 U
L. interrogans Pyrogenes Pyrogenes Salinem
L. borgpetersenii Sejroe Hardjo type bovis Sponselee
L. interrogans Sejroe Hardjo type prajitno Hardjoprajitno
L. borgpetersenii Sejroe Saxkoebing Mus 24
L. borgpetersenii Sejroe Sejroe M 84
L. biflexa* Semaranga Patoc Patoc I
L. meyeri* Semaranga Semaranga Veldrat Semarang 173
L. santarosai Shermani Shermani 1342 K
L. borgpetersenii Tarassovi Tarassovi Perepelitsin
* Nonpathogenic leptospires. All others are pathogenic.
2.4. DNA Isolation
Total nucleic acid extraction from blood and urine samples was performed using The NucliSENS
EasyMAG®automated system (bioMérieux, Marcy l’Etoile, France) according to the manufacturer’s
instructions. Blood samples (K3-EDTA 1 ml tube), were suspended in 2 ml EasyMAG lysis buffer.
Urine samples were centrifuged at 14,000× g 30 minutes at room temperature, the supernatant was
discarded and the pellet was re-suspended in 2 ml EasyMAG lysis buffer. The DNA was eluted in
80 µl elution buffer in the last step of the extraction procedure.
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2.5. TaqMan Real-Time PCR
DNA extracted from cats’ biological materials were tested with TaqMan real-time PCR described
by Ahmed et al., 2020 [25]. Briefly, primers and probe sequences targeting lipL32 gene-specific for
pathogenic Leptospira (LipgrF2, LipgrR2, and LipgrP1) and the internal set primers, probe, and synthetic
internal control template sequences (IntoF2, IntoR2, IntoP1, and PlasintS1) were listed in Table 2. The
PCR analytical sensitivity for the spiked serum, blood, and urine with L. interrogans were estimated as
2, 3, and 5 leptospires per reaction respectively. The PCR as described has a high specificity and is
capable of detecting all pathogenic Leptospira so far known. Between 100–500 copies per reaction of
genomic DNA extracted from Leptospira interrogans strain Kantorowic was used as a positive control.
The PCR was performed, including the internal control template to monitor the reaction performance
and double-distilled DNase/RNase-Free water as a negative control. All clinical samples were tested
in duplicate.
Table 2. Description of the sequence of lipL32, internal set primers, probe, and synthetic internal control
used in the study.
Oligo ID Sequence Sequence Source
LipgrF2 5’CGCTGAAATGGGAGTTCGTATGATTTCC3’ lipL32
LipgrR2 5’GGCATTGATTTTTCTTCYGGGGTWGCC3’ lipL32
LipgrP1 5’FAM AGGCGAAATCGGKGARCCAGGCGAYGG3’BHQ1 lipL32
IntoF2 5’TAGAATCATTGAATCTATCACATCTCATG3’ Internal Control
IntoR2 5’TTGAACTAAATGTAGACTAAAGATGATCG’3 Internal Control
IntoP1 5’TxRd TTCACATTAACATTCAATAATCAATCATGAA3’BHQ2 Internal Control
PlasintS1
5’CTATAGAATCATTGAATCTATCACATCTCATGT
ACTTCACATTAACATTCAATAATCAATCATGAATTAATTCAAT
TTCTGATATGAATCGATCATCTTTAGTCTACATTTAGTTCAATATATC3’
Internal Control
artificial template
The concentration of the reagents and the cyclic amplification protocol were the following; 12.5 ul
of 2x master mix (applied biosystem), 0.4 µM of each leptospires forward and reveres primer (LipgrF2
and LipgrR2), 0.2µM of the leptospires probe (LipgrP1), 0.16µM of each internal control primers (IntoF2
and IntoR2), 0.08 µM of internal control probe (IntoP2), 0.25 µl double-distilled DNase/RNase-free
water and 0.29 pg (equivalent to 50 copy) of internal control DNA template (PlasintS1). Finally, 10 µl
of DNA extracted from cats’ DNA in a total volume of 25 µl were submitted to an amplification
procedure using the CFX96 real-time PCR detection system (Bio-Rad, Amsterdam, The Netherlands).
The cyclic amplification protocol consists of the following steps; initial DNA denaturalization and
DNA polymerase activation at 95 ◦C for 5 minutes, 45 cycles of two steps, 95 ◦C for 20 seconds as
denaturalization and 60 ◦C for 30 seconds as hybridization, and annealing-extension steps for the
probes and each forward and reverse primers respectively.
2.6. Statistical Analysis
Apparent prevalence, 95% CI and CI of a proportion were calculated for antibodies against
Leptospira serovars, leptospiral DNA in blood, leptospiral DNA urinary shedding, FeLV, and FIV
infection with OpenEpi (Andrew G. Dean and Kevin M. Sullivan, Atlanta, GA, USA) [26]. Descriptive
statistics were performed for the calculation of medians, mean, SD, and range. For the possible risk
factors for Leptospira infection, the linearity assumption was first guaranteed with multiple logistic
regression. Age, gender, sampling season, and co-infections with FeLV/FIV were analysed for binary
logistic regression as possible risk factors associated with Leptospira (antibodies presence, amplified
Leptospira DNA in blood and/or urine). A P value <0.05 was determined as statistically significant.
Statistical analysis was performed using a commercial software program (IBM SPSS-Statistics version
22, IBM© Armonk, NY, USA).
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3. Results
In total, 90/244 cats were from Barcelona and 154/244 were from Cáceres, all were domestic
short-haired, 131 cats were male and 113 were female, with ages from 3 months to 16 years (mean 1.8
years and SD 2.30). In addition, 17/244 were FeLV positive (7%, 95% CI: 4.24–11%) and 7/244 were FIV
positive (2.9%; 95% CI: 1.3–5.6%). None of the animals were positive for both diseases (FeLV/FIV). One
hundred and thirty-five cats were sampled in winter, 58 in spring, 15 in summer, and 36 in autumn.
3.1. Seroprevalence
Serum was obtained from all animals and 10/244 cats (4.1–95% CI: 2.1–7.18%), 9 from Cáceres
and only one from Barcelona; 8 males and 2 females with ages ranged from 6 months to 6 years, were
seropositive (antibody titers ranged from 1:20 to 1:320) for at least one serovar. Only two cats had
antibody titers ≥ 1:320 against the serovars Bataviae and Proechimys (Table 3).
Table 3. Seropositive Microscopic agglutination test (MAT) results among 244 cats tested in Spain.
Gender Age y.o. Origin Titer Species Serogroup Serovar Strain FIV FeLV
F 1 C 1:20 L. borgpetersenii Ballum Ballum Mus 127 N N
M 0.5 C 1:201:20
L. interrogans
L. kirschneri
Australis
Cynopteri
Bratislava
Cynopteri
Jez Bratislava
3522 C N N
M 1 C 1:20 L. kirschneri Cynopteri Cynopteri 3522 C N N
M 2 C 1:20 L. kirschneri Cynopteri Cynopteri 3522 C N N
M 2 C 1:40 L. kirschneri Cynopteri Cynopteri 3522 C N N
M 2 C 1:320 L. interrogans Bataviae Bataviae Swart N N
M 5 C 1:20 L. borgpetersenii Ballum Ballum Mus 127 N N
F 1 C
1:20
1:20
1:80
1:40
1:20
1:80
1:320
L. interrogans
L. kirschneri
L. kirschneri
L. kirschneri
L. interrogans
L. noguchii
L. interrogans
Australis
Cynopteri
Grippotyphosa
Grippotyphosa
Pomona
Pomona
Autumnalis
Bratislava
Cynopteri
Grippotyphosa
Grippotyphosa-M
Pomona
Proechimys
Rachmati
Jez Bratislava
3522 C
Mandemakers
Moskva V
Pomona
1161 U
Rachmat
N N
M 2 C 1:201:20
L. interrogans
L. noguchii
Pomona
Pomoma
Pomona
Proechimys
Pomona
1161 U P N
nM 7 B 1:20 L. borgpetersenii Sejroe Sejroe M 84 N N
F: Female; M: Male; nM: Neutered male; C: Cáceres, Extremadura; B: Barcelona, Catalonia; N: Negative; P: Positive,
FeLV: feline leukaemia virus, FIV: feline immunodeficiency virus.
The most common serovars involved in the study were Cynopteri (5/10 of seropositive cats)
followed by serovars Ballum, Bratislava, Grippotyphosa, and Proechimys. Antibodies titers for at
least two serovars belonging to two different serogroups were detected in 2 cats. None of the cats
with antibodies shed pathogenic Leptospira DNA in their urine. All animals were negative against
saprophytic strains included in the panel.
3.2. DNA Detection in Blood PCR
Due to the low volume of the blood sample obtained during sampling in some animals, DNA
isolation from blood samples was only possible in 89/244 cats. Only one sample (8-month-old female
from Barcelona), was positive (1.12%; 95% CI: 0.05–5.41%). This cat had no antibodies against Leptospira
detected by MAT (Table 4).
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Table 4. Results of DNA detection in blood and urinary shedding by polymerase chain reaction (PCR)
in cats from Spain.
Gender Age y.o. Origin
Blood DNA
Amplification by
PCR (n = 89)
Urine DNA
Amplification by
PCR (n = 232)
FIV FeLV
F 1 C N N N N
M 0.5 C N N N N
M 1 C N N N N
M 2 C N N N N
M 2 C N N N N
M 2 C N N N N
M 5 C N N N N
F 1 C N N N N
M 2 C N N P N
nM 7 B N N N N
M 0.5 C N P N N
F 1 C N P N N
M 0.5 B N P N N
F 0.5 B N P N N
F 0.6 B P N N N
F: Female, M: Male, nM: Neutered male, y.o: Years old, C: Cáceres, B: Barcelona, U PCR: Urinary PCR, B PCR: Blood
PCR, N: Negative, P: Positive.
3.3. Urinary Shedding
It was not possible to collect urine in 12 cats and therefore, 232 urine samples were processed
for DNA extraction and subsequently PCR testing. A total of 4/232 samples amplified DNA from
pathogenic Leptospira species (1.72%; 95% CI: 0.55–4.10%); two cats (1 male and 1 female) were from
Cáceres and two cats (1 male and 1 female) were from Barcelona. All positive cats were ≥1-year-old
(Table 4). All PCR negative controls tested negative and all PCR positive controls tested positive. None
of these cats had antibodies against Leptospira by MAT.
3.4. Risk Factor Analysis
Multivariate logistic regression did not reveal significant risk factors for Leptospira infection neither
for seroprevalence nor DNA detection in blood and/or urine in the present study; P values were ≥0.05.
4. Discussion
Cats are susceptible to Leptospira [9,10,12,27] and the presence of viable pathogenic leptospires
in the urine of cats has been proven (p. 227, [19,28]). Therefore, the species can play a role in the
transmission of the zoonosis. Cats are becoming more popular as a companion animal and it is therefore
important to have data to assess the extent to which cats constitute a risk of human leptospiral infection.
Scant information is known about specific characteristics of leptospirosis pathogenesis in cats.
Based on general knowledge of the disease, once an animal becomes infected it may develop the
incidental host state with the presentation of acute illness, that may be fatal, or chronic renal carrier
state with mild or non-presenting clinical signs [23]. There are some differences in the disease
presentation linked to the infecting serovar [29]. Leptospires enter the warmer body environment and
transcriptional changes occur that enhance their pathogenicity [23]. In rats and mice (chronic carrier
host), the regulation of Leptospira lipopolysaccharide (LPS) differs from human and dogs (incidental
host) [30,31]. In murine species, there is an adaptation of the innate response to infection with
leptospires [32]. In carrier hosts (rats and mice), leptospires are disseminated through the organism
and are most likely cleared by the immune system from all tissues except the kidney. In the epithelial
cells of the renal tubules, leptospires continue to multiply and are shed in the urine [33].
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Based on experimental infections and previous reports on cats, leptospiraemia may be present
in the first hours of infection [34], but on average, it appears from 6 days post-infection and lasts up
to 7 more days [35]; antibody titer rises at the end of the first week of infection [34], the peak titer
has been reported to be around day 21 [35] but in many cases, cats unlike dogs, do not develop a
high antibody titer [34–36]. In other species, antibodies last from months to years [2,23], but it has
not yet been confirmed in cats. The shedding of leptospires in cats’ urine appears from 2–4 weeks
post-infection and it could last at a maximum of 6 weeks in case of acute disease (incidental host
state) [34,35]. Acute cases of feline leptospirosis, however are scarce nevertheless, epidemiological
studies on leptospires prevalence demonstrate that the role of cats is mostly as a chronic carrier. In a
cat, urinary shedding of pathogenic Leptospira has been demonstrated for a period of 8 months [15].
Based on the above information, it is our belief that cats as the murine species act most as the chronic
carrier than an incidental host for the disease.
Seroprevalence against Leptospira observed in our study (4.1% positive 95% CI: 2.1–7.18%), fell
within the previous intervals described worldwide, 4% to 33.3% [14,16,17,37]. Environmental factors
such as outdoor habits, presence of farm animals that may shed leptospires in the neighborhood, prey
habits, or even the season of the year (resulting in different levels of exposure to pathogenic leptospires),
can explain the broad ranges of antibody prevalence reported in the literature. Even different cut off
values (≥1:100) and serovar panels used in laboratories may affect the prevalence. All these factors,
along with a different length of sampling (3 years) and sample size (n = 53), may explain the prevalence
(14%) obtained previously in the country [38], compared with the lower prevalence in our study (4.1%).
Except for two cats from Cáceres (titer 1:320), antibody titers of the animals in our study were
not ≥1:100. Adler, 2014 [23], reported that infected animals may have MAT titers below 1:100; which
is supported by epidemiological studies in cats [13,14,16,39]. Seropositive animals in our study
demonstrate previous evidence of contact with Leptospira. They could have had a recent infection,
as cats are not as routinely vaccinated against the disease as dogs, or they were chronically infected
animals with falling antibody titers.
At the time of sampling, both cats with titers ≥1:320 showed no urinary shedding of Leptospira
DNA. Nevertheless, we were unable to take further urine samples from these animals at different
times (as per Weis et al., 2017) [15] in order to confirm if they had intermittent shedding of the bacteria
DNA. To our knowledge, this is the first study in Spain to confirm by MAT, the seropositivity against
serovars Bataviae, Bratislava, Cynopteri, Grippotyphosa, Pomona, Proechimys, and Rachmati in
cats, suggesting the possible presence of serovars from serogroups Australis, Autumnalis, Bataviae,
Cynopteri, Grippotyphosa, and Pomona among cats in the country. In the metropolitan area of
Barcelona, Spain, the presence of members of serogroups Australis, Bataviae, and Grippotyphosa (also
detected in our study in cats) has been detected in small mammals [40], so it may be possible for serovars
to circulate between animal species. Another factor to consider is the increased contact between cats and
animal reservoirs of leptospires, due to shifts in the dynamics and colonization of cities. Environmental
changes often increase the frequency and magnitude of contact between wild and domestic species, thus
increasing the risk of disease transmission. Leptospirosis is an example of this dynamic interface with
wildlife [41]. Serovars belonging serogroups Australis, Autumnalis, Batavie, Bratislava, Grippotyphosa,
and Pomona have been previously described in cats from Europe [12,15,16,27,39,42].
A cross-sectional epidemiological Leptospira study was recently conducted in dogs from Spain [43];
however, serovars from serogroups Ballum, Bataviae, and Cynopteri, were not part of the diagnostic
panel, unlike our study of cats which included them. Antibodies against serovars of these serogroups
were present in the cats of our study. The variety and number of serovars and serogroups included in
the diagnostic panel have a direct relationship with the sub-diagnosis of leptospirosis by MAT [44].
Generally speaking, cross-reactivity between leptospiral serogroups has been previously described.
In dogs, antibody titers to heterologous strains may provide equal or higher titers than the infecting
serovar [23]. A second test performed 15 days after the first one, could help determine the infecting
serovar due to seroconversion. Although, still caution is needed since presumptive serogroup data
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should be used only to give a broad idea of the common serogroups present in a population and cannot
be interpreted reliably in individual patients [45]. In the present study, 3 cats had antibody titers
against more than one serovar (Table 3). Previously published studies [15,20,46] have also reported
cats simultaneously seropositive against different serovars. The simultaneous seropositivity that some
cats display, not only in our study but in others, could be explained by either a genuine cross-reactivity
in cats or by the simultaneous exposure of the animals to different serovars belonging to different
serogroups. In the case of the one-year-old female cat from Cáceres, she had antibodies against 7
different serovars. Surely in the case of the serovars belonging to serogroup Pomona, it represents a
cross-reaction with the highest titer obtained.
Cynopteri (belonging a Cynopteri serogroup) was the most frequently detected serovar, in our
study. In all cases, the infected animals came from Cáceres; therefore, there is a possibility that a serovar
from this serogroup is endemic in the cat population of this region. None of the seropositive cats shed
Leptospira DNA in their urine. A plausible explanation for this could be that either the animals had an
acute infection with increasing antibody titers at the moment of sampling and no shedding of Leptospira
DNA had occurred yet, or most likely that they were chronic carriers with falling or steady antibody
titers and non-continuous Leptospira shedding in the urine. Similar findings have been previously
described [14,15,18,20].
According to the World Health Organization’s guidance [24], the diagnostic panel of antigens
used in MAT should include local strains, which increases the sensitivity of the technique compared to
reference strains. However, the range of serovars should not be limited to local strains as the infection
may be caused by a rare serovar or a strain not previously described. For this reason, we included
saprophytic strains (L. biflexa strain Patoc I, L. biflexa strain CH 11, and L. meyeri strain Veldrat Semarang
173) in our panel diagnostic, which can cross-react with the antibodies generated by some pathogenic
serovars. Possible explanations for the fact that none of the cats with antibodies against pathogenic
leptospires had antibodies against the saprophytic serovars included in our MAT panel, could be that
they have not either specific cross-reactivity against the used saprophytic ones or because as it has
been described previously, the saprophytic serovars, specifically serovar Patoc, has limited ability to
detect cross-reactions with antibodies of past infections [47].
The presence of leptospires in cats’ blood has been reported in clinical cases and in epidemiological
research [6,10]. In our study, isolation of pathogenic Leptospira DNA in blood was only possible in 1
out of 89 cats. This cat was negative to FeLV/FIV tests, was seronegative against Leptospira and did not
shed pathogenic leptospires DNA by urine. Therefore, we conclude that the animal was at an early
stage of leptospirosis, with clinical signs non-present.
One epidemiological study in Taiwan, using serum and urine samples of cats [6], reported
prevalence by PCR of 19.1% in blood and 67.8% in urine respectively. The differences in prevalence
between this study and ours may be due to several factors such as i) Different primers used between
studies. Chan et al., 2014 [6] used two sets of primers, the first one Leptospira rrs (16S) which is not able
to differentiate between non-pathogenic Leptospira biflexa and pathogenic Leptospira spp. The second
one primer set G1/G2 amplified a 285-bp sequence by PCR from strains of all pathogenic Leptospira
spp. except for Leptospira kirschneri. This fact leads to differences between sensitivity and specificity in
the PCR techniques used between studies. ii) The origin of the cats sampled in Taiwan; most of them
came from rural areas; iii) The climatic conditions related to Taiwan, where typhoons are frequent and
therefore favor the conditions for the maintenance of the leptospires in the environment; and iv) They
used a random sample of cats which included shelter and household cats.
The prevalence of urinary shedding from leptospiral DNA in the present research is consistent
with that reported in previous studies in cats [6,7,14,15,18,19]. Our results also match with those
obtained by Sprißler et al., 2018 (0.8%) [14] and Gomard et al., 2019 (0.6%) [8]. In common, the two
PCRs methodologies used in these two studies and in our work are targeting the lipL32 gene [25,48]. In
a sample of healthy cats and cats suffering from kidney disease, Rodriguez et al., 2014 [20] described
a urinary prevalence of 14.9% in the latter group. Our results are not comparable with those, as the
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animals in our study were part of a free-roaming or shelter neutering program and at the time of
sampling, none of the 4 cats showed clinical signs of disease. In cats, the urinary shedding time of
Leptospira DNA remains unknown. Urine cultures of the cats in our study were not carried out due to
the cumbersome and time-consuming nature of the methodology. The fact that none of the urinary
shedding cats had antibody titers by MAT, may indicate that they have been chronically infected
animals with falling, steady, or non-present antibody titers at the moment of sampling [35,36]. The
MAT test has limitations detecting renal carriers [23]. The panel used in our study was broad, 8 species
of Leptospira, belonging to 20 serogroups, 27 serovars, and 28 strains even including non-pathogenic
serovars, so we can rule out the possibility that the Leptospira infection was sub-diagnosed.
One limitation of the research was that it was not possible to perform a follow up of tests of the
cats, in order to determine seroconversion and the urinary shedding of pathogenic Leptospira DNA
over time. This was due to the cats’ origin, as mentioned above.
5. Conclusions
In conclusion, this study reports seropositivity by MAT, against serovars belonging serogroups
Australis, Autumnalis, Bataviae, Cynopteri, Grippotyphosa, and Pomona, for the first time in cats
from Spain. Moreover, the antibodies against serovar Cynopteri (serogroup Cynopteri) were the
most frequently detected in cats from Cáceres (Extremadura, southwest Spain). Knowledge of the
involved leptospiral serovars in animals from any country is imperative for the accurate diagnostics
and epidemiological surveillance of the disease. Therefore, we recommend including at least the
aforementioned serogroups in any MAT panels used by diagnostic laboratories for detecting leptospiral
antibodies in cats as well as dogs from Spain.
To our knowledge, this is the first report of urinary shedding of pathogenic leptospiral DNA in
cats from Spain, diagnosed by means of molecular tools targeting the lipL32 gene. Free-roaming cats in
Spain can shed Leptospira DNA in their urine and may be a source of infection for people. Although the
presence of viable leptospires in urine culture from cats has already been shown (p. 227, [19]), more
prospective studies should be performed to ascertain the role of cats in the spread of the zoonosis.
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